[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$ipsey
Social media buzz around $CRNX is high, with analysts and users excited about the potential of Palsonify. The drug is seen as a potential game-changer in endocrine treatments.
About $ipsey
A social media analysis of the $ipsey topic, likely related to a financial asset or company.
Engagements: XXX #
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Month: XXXXX -XX%
1-Year High: XXXXX on 2025-06-20
1-Year Low: X on 2025-07-05
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: XX -XX%
1 Month: XX no change
1-Year High: XX on 2025-05-31
1-Year Low: X on 2025-06-26
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $ipsey in the last XX hours which is up XX% from X in the previous XX hours
Daily Average: X
1 Week: X no change
1 Month: XX +20%
1-Year High: X on 2025-06-21
1-Year Low: X on 2025-04-27
The most influential creators that mention $ipsey in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Quantumup1 | X | XXXXX | X | XXX |
Top assets mentioned In the posts about $ipsey in the last XX hours
Novartis AG (NVS) Lunyr (LUN) Crinetics Pharmaceuticals, Inc. (CRNX) Verisk Analytics, Inc. (VRSK) Tyler Technologies, Inc. (TYL) Exelixis Inc (EXEL)
Top topics mentioned In the posts about $ipsey in the last XX hours
$nvs, $bchmy, teva, $legn, $lun, $crnx, op, $xers, $97top, $30s, $vrsk, $tyl, $tiog, $thkly, $tei, ter, exas, googl, bdx, $bimpa, $sgopa, $gloppa, thc, $ipnpa, $ipsef, $exel
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Piper Sandler y'day reit'd $CRNX OW-$97-Top Pick afterš£w/ a Leading ENDOhe Tx's a couple hundred acromegaly ptsplans to offer PALSONIFY immediately to almost all pts +was impressed w/ atumelnant's Ph1b/2a Cushing's data/is +VE on this opp $BCHMY $IPSEY $NVS $CORT $XERS Piper Sandler in its note to investors said:"
@Quantumup1 on X 2025-07-22 18:41:19 UTC 3517 followers, 1727 engagements
"$CRNX (L) have been adding since it dropped into the $30s think paltusotine would be a game changer for patients prev relied on injections or twice daily oral drug before. Undisputed leader in endocrine"
@streamtailvents on X 2025-07-22 10:35:27 UTC XX followers, XXX engagements
"H.C. Wainwright reiterated $CRNX Buy-$81 and said "At the #ENDO 2025 conference we felt strong enthusiasm towards Palsonify (paltusotine) from many expert endocrinologists." $BCHMY $IPSEY $NVS #ENDO2025 H.C. Wainwright added "They were all excited about the drug's compelling efficacy and durability on top of a convenient once-daily dosing regimen. Many called it a "game changer" in acromegaly compared to the current standard-of-care whether intramuscular somatostatin receptor ligands (SRL) injections or twice-daily oral SRLs. Unlike the injectables paltusotine has been shown to provide"
@Quantumup1 on X 2025-07-21 17:37:06 UTC 3517 followers, 3678 engagements